Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Boston Scientific Corp.
(NY:
BSX
)
9.080
USD
-0.080 (-0.87%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
18,912,195
Open
9.080
Bid (Size)
9.060 (100)
Ask (Size)
9.070 (600)
Prev. Close
9.160
Today's Range
9.040 - 9.170
52wk Range
4.790 - 9.390
Shares Outstanding
1,349,092,384
Dividend Yield
N/A
Top News
More News
Special Situation Coming Soon, a Look Inside WFC, CERP, BSX and YHOO
May 24, 2013
from
Marketwired News Releases
Boston Scientific To Participate In The 38th Annual Deutsche Bank 2013 Healthcare Conference
May 24, 2013
from
PR Newswire
More News
Read More
Belo Sun Reports Positive Results From Preliminary Metallurgical Leach Test Work Conducted With Volta Grande South Block Samples With Average Recoveries of 95% and Reports AGM Results
May 23, 2013
from
Marketwired
Profitable Trading Secrets Revealed in BSX and CERP
May 23, 2013
from
Marketwired News Releases
Medtronic’s Defibrillators Sales Show A Pulse In Encouraging Results
May 22, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
May 22, 2013
from
PR Newswire
Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial
May 22, 2013
from
PR Newswire
Boston Scientific Announces Results from Promus Premier, Synergy Drug-Eluting Stent
May 22, 2013
category
Benzinga
,
BSX
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
Boston Scientific (BSX) Reports Positive Results from NG PROMUS, EVOLVE
May 22, 2013
from
StreetInsider.com News Articles
Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data
May 22, 2013
from
PR Newswire
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here